Article
NadA, a novel vaccine candidate of Neisseria meningitidis.
The Journal of experimental medicine - 3 Jun 2002
Comanducci Maurizio, Bambini Stefania, Brunelli Brunella, Adu-Bobie Jeannette, Aricò Beatrice, Capecchi Barbara, Giuliani Marzia Monica, Masignani Vega, Santini Laura, Savino Silvana, Granoff Dan M, Caugant Dominique A, Pizza Mariagrazia, Rappuoli Rino, Mora Marirosa
Abstract excerpt
Neisseria meningitidis is a human pathogen, which, in spite of antibiotic therapy, is still a major cause of mortality due to sepsis and meningitis. Here we describe NadA, a novel surface antigen of N. meningitidis that is present in 52 out of 53 strains of hypervirulent lineages electrophoretic types (ET) ET37, ET5, and cluster A4. The gene is absent in the hypervirulent lineage III, in N. gonorrhoeae and in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
